I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
SHR2285, the first selectively oral FXIa inhibitor in China..:
Tingting Ma
;
Yanli Dong
;
Lei Huang
...
https://www.frontiersin.org/articles/10.3389/fphar.2022.1027627/full. , 2022
Link:
https://doi.org/10.3389/fphar.2022.1027627
RT Journal T1 <Title>SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:56e9582c6fd946c5ad8eedbac29d0185&Exemplar=1&LAN=DE A1 Tingting Ma A1 Yanli Dong A1 Lei Huang A1 Yuanxun Yang A1 Yan Geng A1 Fei Fei A1 Pinhao Xie A1 Yu Zhao A1 Hui Lin A1 Zeyu Yang A1 Yun Jin A1 Xitong Ju A1 Runbin Sun A1 Juan Li PB Frontiers Media S.A. YR 2022 K1 anticoagulants K1 coagulation factor inhibitor K1 dual antiplatelet therapy K1 pharmacodynamics K1 pharmacokinetics K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2022.1027627/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2022.1027627 DO https://doi.org/10.3389/fphar.2022.1027627 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
